WallStSmart

Cigna Corp (CI)vsToyota Motor Corporation ADR (TM)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Toyota Motor Corporation ADR generates 18139% more annual revenue ($50.68T vs $277.89B). TM leads profitability with a 7.6% profit margin vs 2.3%. CI appears more attractively valued with a PEG of 0.88. CI earns a higher WallStSmart Score of 68/100 (B-).

CI

Strong Buy

68

out of 100

Grade: B-

Growth: 6.7Profit: 5.5Value: 9.3Quality: 5.5
Piotroski: 5/9Altman Z: 2.50

TM

Buy

60

out of 100

Grade: C+

Growth: 6.7Profit: 4.5Value: 6.3Quality: 4.5
Piotroski: 3/9Altman Z: 1.68
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

CIUndervalued (+57.1%)

Margin of Safety

+57.1%

Fair Value

$680.85

Current Price

$289.48

$391.37 discount

UndervaluedFair: $680.85Overvalued

Intrinsic value data unavailable for TM.

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

CI5 strengths · Avg: 8.6/10
P/E RatioValuation
11.8x10/10

Attractively priced relative to earnings

Market CapQuality
$77.73B9/10

Large-cap with strong market position

PEG RatioValuation
0.888/10

Growing faster than its price suggests

Price/BookValuation
1.8x8/10

Reasonable price relative to book value

EPS GrowthGrowth
29.1%8/10

Earnings expanding 29.1% YoY

TM4 strengths · Avg: 9.5/10
Market CapQuality
$228.02B10/10

Mega-cap, among the largest globally

P/E RatioValuation
9.5x10/10

Attractively priced relative to earnings

Free Cash FlowQuality
$398.23B10/10

Generating 398.2B in free cash flow

EPS GrowthGrowth
23.2%8/10

Earnings expanding 23.2% YoY

Areas to Watch

CI2 concerns · Avg: 3.5/10
Revenue GrowthGrowth
4.6%4/10

4.6% revenue growth

Profit MarginProfitability
2.3%3/10

2.3% margin — thin

TM4 concerns · Avg: 4.0/10
PEG RatioValuation
1.544/10

Expensive relative to growth rate

Price/BookValuation
15.1x4/10

Trading at 15.1x book value

Revenue GrowthGrowth
1.9%4/10

1.9% revenue growth

Altman Z-ScoreHealth
1.684/10

Distress zone — elevated risk

Comparative Analysis Report

WallStSmart Research

Bull Case : CI

The strongest argument for CI centers on P/E Ratio, Market Cap, PEG Ratio. PEG of 0.88 suggests the stock is reasonably priced for its growth.

Bull Case : TM

The strongest argument for TM centers on Market Cap, P/E Ratio, Free Cash Flow.

Bear Case : CI

The primary concerns for CI are Revenue Growth, Profit Margin. Thin 2.3% margins leave little buffer for downturns.

Bear Case : TM

The primary concerns for TM are PEG Ratio, Price/Book, Revenue Growth.

Key Dynamics to Monitor

TM carries more volatility with a beta of 0.31 — expect wider price swings.

CI is growing revenue faster at 4.6% — sustainability is the question.

TM generates stronger free cash flow (398.2B), providing more financial flexibility.

Monitor HEALTHCARE PLANS industry trends, competitive dynamics, and regulatory changes.

Bottom Line

CI scores higher overall (68/100 vs 60/100). Both earn "Strong Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Cigna Corp

HEALTHCARE · HEALTHCARE PLANS · USA

Cigna is an American multinational managed healthcare and insurance company based in Bloomfield, Connecticut. Its insurance subsidiaries are major providers of medical, dental, disability, life and accident insurance and related products and services, the majority of which are offered through employers and other groups (e.g. governmental and non-governmental organizations, unions and associations).

Visit Website →

Toyota Motor Corporation ADR

CONSUMER CYCLICAL · AUTO MANUFACTURERS · USA

Toyota Motor Corporation designs, manufactures, assembles and sells passenger cars, minivans and commercial vehicles, and related parts and accessories. The company is headquartered in Toyota, Japan.

Want to dig deeper into these stocks?